Meta-Analysis of Serious Infections with Tofacitinib and Biological Treatment in Rheumatoid Arthritis Clinical Trials

被引:0
|
作者
Strand, V.
Ahadieh, S. [1 ]
French, J. [2 ]
Geier, J. [3 ]
Krishnaswami, S. [4 ]
Menon, S. [4 ]
Checchio, T. [1 ]
Riese, R. [5 ]
Gomez-Reino, J. [6 ]
机构
[1] Pfizer Inc, Pharmacometr, Groton, CT 06340 USA
[2] Metrum Res Grp, Tariffville, CT USA
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Clin Pharmacol, Groton, CT 06340 USA
[5] Pfizer Inc, Groton, CT 06340 USA
[6] Univ Santiago, Hosp Clin, E-15706 Santiago, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
458
引用
收藏
页码:S195 / S196
页数:2
相关论文
共 50 条
  • [1] Meta-analysis of serious infections with tofacitinib and biological treatment in rheumatoid arthritis clinical trials.
    Strand, Vibeke
    Ahadieh, Sima
    French, Jonathan
    Geier, Jamie
    Krishnaswami, Sriram
    Menon, Sujatha
    Checchio, Tina
    Boy, Mary
    Riese, Richard
    Gomez-Reino, Juan
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E224 - E224
  • [2] Meta-Analysis of Malignancies, Serious Infections, and Serious Adverse Events with Tofacitinib or Biologic Treatment in Rheumatoid Arthritis Clinical Trials
    Ahadieh, Sima
    Checchio, Tina
    Tensfeldt, Thomas
    French, Jonathan
    Geier, Jamie
    Riese, Richard
    Menon, Sujatha
    Boy, Mary
    Krishnaswami, Sriram
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S93 - S94
  • [3] Meta-Analysis of Malignancies, Serious Infections, and Serious Adverse Events with Tofacitinib or Biologic Treatment in Rheumatoid Arthritis Clinical Trials.
    Ahadieh, Sima
    Checchio, Tina
    Tensfeldt, Thomas
    French, Jonathan
    Krishnaswami, Sriram
    Riese, Richard
    Menon, Sujatha
    Boy, Mary G.
    Geier, Jamie L.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S726 - S726
  • [4] META-ANALYSIS OF SERIOUS INFECTIONS WITH BARICITINIB, TOFACITINIB AND BIOLOGIC DMARDS IN RHEUMATOID ARTHRITIS
    Strand, V.
    Ahadieh, S.
    DeMasi, R.
    Krishnaswami, S.
    Geier, J.
    Menon, S.
    Gomez-Reino, J. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 284 - 284
  • [5] Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
    Vibeke Strand
    Sima Ahadieh
    Jonathan French
    Jamie Geier
    Sriram Krishnaswami
    Sujatha Menon
    Tina Checchio
    Thomas G. Tensfeldt
    Elaine Hoffman
    Richard Riese
    Mary Boy
    Juan J. Gómez-Reino
    [J]. Arthritis Research & Therapy, 17
  • [6] Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
    Strand, Vibeke
    Ahadieh, Sima
    French, Jonathan
    Geier, Jamie
    Krishnaswami, Sriram
    Menon, Sujatha
    Checchio, Tina
    Tensfeldt, Thomas G.
    Hoffman, Elaine
    Riese, Richard
    Boy, Mary
    Gomez-Reino, Juan J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [7] Infections and serious infections as risks of rituximab in rheumatoid arthritis. Results from an updated meta-analysis of randomised clinical trials
    Velez-Nandayapa, L.
    DeVore, L.
    Parikh, C.
    [J]. DRUG SAFETY, 2017, 40 (10) : 990 - 991
  • [8] The Risk of Infections and Serious Infections with Rituximab in Rheumatoid Arthritis. Results from an Updated Meta-Analysis of Randomised Clinical Trials
    Velez-Nandayapa, Luis
    DeVore, Laura
    Parikh, Chahna
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 380 - 381
  • [9] Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis: a Systematic Review and Meta-Analysis
    He, Y.
    Wong, A.
    Chan, E.
    Lau, W.
    Man, K.
    Chui, C.
    Worsley, A.
    Wong, I.
    [J]. DRUG SAFETY, 2013, 36 (09) : 852 - 853
  • [10] Clinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials
    Li, Hongchao
    Man, Siliang
    Zhang, Liang
    Hu, Lidong
    Song, Hui
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022